H. Lesch

T. Wirth, S. Ylä-Herttuala, M. Kaikkonen, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Experimental Evaluation of an Interferometric Light Microscopy Particle Counter for Titering and Characterization of Virus Preparations

S. Ylä-Herttuala, H. Lesch, V. Turkki, 2021, Viruses.

Requirements for baculoviruses for clinical gene therapy applications.

K. Airenne, S. Ylä-Herttuala, K. Makkonen, 2011, Journal of invertebrate pathology.

Differential Promoter Methylation of Macrophage Genes Is Associated With Impaired Vascular Growth in Ischemic Muscles of Hyperlipidemic and Type 2 Diabetic Mice: Genome-Wide Promoter Methylation Study.

S. Ylä-Herttuala, A. Gyenesei, B. Ghimire, 2015, Circulation research.

Lentiviral Vectors for Gene Therapy Targeting, Imaging and Baculovirus Mediated New Method for Lentivirus Production

H. Lesch, 2009 .

Biodistribution and antitumor effect of Cetuximab-targeted lentivirus.

S. Ylä-Herttuala, M. Kaikkonen, A. Närvänen, 2014, Nuclear medicine and biology.

Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector Production

Hanna Leinonen, Saana Lepola, Eevi Maria Lipponen, 2020, Human gene therapy.

Tissue damage drives co-localization of NF-κB, Smad3, and Nrf2 to direct Rev-erb sensitive wound repair in mouse macrophages

C. Glass, R. Evans, N. Spann, 2016, eLife.

Improving safety of gene therapy.

T. Wirth, S. Ylä-Herttuala, J. Räty, 2008, Current drug safety.

Evaluation of the Single‐Use Fixed‐Bed Bioreactors in Scalable Virus Production

Hanna P Lesch, Minna Karhinen, Piia Valonen, 2020, Biotechnology journal.

Generation of lentivirus vectors using recombinant baculoviruses

K. Airenne, E. Niskanen, S. Ylä-Herttuala, 2008, Gene Therapy.

Functional roles of the membrane-associated AAV protein MAAP

K. Airenne, S. Ylä-Herttuala, Vesa Aho, 2021, Scientific Reports.

Process Development of Adenoviral Vector Production in Fixed Bed Bioreactor: From Bench to Commercial Scale.

Seppo Ylä-Herttuala, Piia Valonen, Achim Müller, 2015, Human gene therapy.

Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors

K. Airenne, P. Alves, M. Carrondo, 2011, Gene Therapy.

Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.

K. Airenne, H. Uusitalo, G. Kalesnykas, 2017, Current gene therapy.

A 96-well format for a high-throughput baculovirus generation, fast titering and recombinant protein production in insect and mammalian cells

O. Laitinen, K. Airenne, S. Ylä-Herttuala, 2009, BMC Research Notes.

Lentiviral Protein Transduction with Genome-Modifying HIV-1 Integrase-I-PpoI Fusion Proteins: Studies on Specificity and Cytotoxicity

S. Ylä-Herttuala, H. Lesch, Tiia Husso, 2014, BioMed research international.

Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy

K. Airenne, S. Ylä-Herttuala, H. Lesch, 2022, Frontiers in Medicine.

Detection of lentiviral suicide gene therapy in C6 rat glioma using hyperpolarised [1‐13C]pyruvate

Hanna P Lesch, Seppo Ylä-Herttuala, Jan Henrik Ardenkjaer-Larsen, 2020, NMR in biomedicine.

Avidin fusion protein-expressing lentiviral vector for targeted drug delivery.

K. Airenne, T. Wirth, S. Ylä-Herttuala, 2009, Human gene therapy.

Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing.

H. Lesch, A. Kailaanmäki, Piia Käyhty, 2024, Cytotherapy.